Latest news
{{'Wed, 01 Jul 2026 07:00:00 -0400' | dateFormatUsFilter}}
Wegovy® is now accessible to eligible Medicare beneficiaries living with obesity through Medicare GLP-1 Bridge
Read more
{{'Fri, 26 Jun 2026 09:00:00 -0400' | dateFormatUsFilter}}
Novo Nordisk to showcase new data across its hemophilia portfolio at the ISTH Congress 2026, featuring investigational denecimig
Read more
{{'Sun, 07 Jun 2026 17:30:00 -0400' | dateFormatUsFilter}}
Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.